publication venue for
- The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype.. -. 2023
- Dopamine D3 receptor ligand suppresses the expression of levodopa-induced dyskinesia in nonhuman primate model of parkinson's disease.. -. 2021
- Neural-respiratory inflammasome axis in traumatic brain injury.. -. 2019
- The accumulation of T cells within acellular nerve allografts is length-dependent and critical for nerve regeneration.. 216-231. 2019
- Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes.. 298:191-201. 2017
- Targeting urate to reduce oxidative stress in Parkinson disease.. 298:210-224. 2017
- Phrenic motor neuron TrkB expression is necessary for acute intermittent hypoxia-induced phrenic long-term facilitation.. 287:130-136. 2016
- Gastrin-releasing peptide facilitates glutamatergic transmission in the hippocampus and effectively prevents vascular dementia induced cognitive and synaptic plasticity deficits.. 287:75-83. 2016
- Pattern recognition receptors and central nervous system repair.. 5-16. 2014
- Protection by vascular prostaglandin E2 signaling in hypoxic-ischemic encephalopathy.. 30-7. 2014
- Commentary: Progressive inflammation as a contributing factor to early development of Parkinson's disease.. 148-55. 2012
- Preclinical jockeying on the translational track of adenosine A2A receptors.. 228:160-4. 2011
- Dynamic quantification of host Schwann cell migration into peripheral nerve allografts.. 225:310-9. 2010
- Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration.. 223:657-61. 2010
- Targeting Abeta and tau in Alzheimer's disease, an early interim report.. 223:252-66. 2009
- Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos.. 218:193-202. 2009
- Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor.. 217:63-73. 2009
- Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse.. 217:124-35. 2009
- Long-term cognitive dysfunction following experimental subarachnoid hemorrhage: new perspectives.. 213:336-44. 2008
- The impact of motor and sensory nerve architecture on nerve regeneration.. 212:370-6. 2008
- Amperometric measures of age-related changes in glutamate regulation in the cortex of rhesus monkeys.. 208:238-46. 2007
- Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury.. 206:59-69. 2007
- Detection of traumatic axonal injury with diffusion tensor imaging in a mouse model of traumatic brain injury.. 205:116-31. 2007
- A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury.. 192:109-16. 2005
- Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging.. 191:77-85. 2005
- Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury.. 197:330-40. 2005
- A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease.. 184:285-94. 2003
- In vivo electrochemical studies of dopamine clearance in subregions of rat nucleus accumbens: differential properties of the core and shell.. 153:277-86. 1998
- Receptor alterations in subcortical structures after bilateral middle cerebral artery infarction of the cerebral cortex.. 128:88-96. 1994
- Alterations in target innervation and collateral sprouting in the aging sympathetic nervous system.. 124:381-6. 1993
- Transynaptic regulation of low-affinity p75 nerve growth factor receptor mRNA precedes and accompanies lesion-induced collateral neuronal sprouting.. 118:73-84. 1992
- Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra.. 111:282-92. 1991
- Nigral dopamine type-1 receptors are reduced in Huntington's disease: a postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin binding.. 110:219-27. 1990